RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$141.81
-0.70 (-0.49%)
Analyst Consensus
Strong Buy
27
Analysts
High
Coverage
Price Target
Analyst Price Target
-19.5% upside
Low Target
$80.83
Average Target
$114.11
High Target
$120.13
Current Price
$141.81
Current
$141.81
$141.81
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Scenario Analysis
Bear Case
$80.83
-43.0%
Low target
Base Case
$114.11
-19.5%
Avg target
Bull Case
$120.13
+-15.3%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$155.70
-8.9% from high
52-Week Low
$34.00
+317.1% from low
50-Day SMA
$94.85
+49.5% vs SMA
200-Day SMA
$58.23
+143.5% vs SMA
RSI (14)
62.5
Neutral
Target vs 52W High
$114.11
-26.7% vs high
Next Earnings Report
May 11, 2026 · After Market Close
Today
EPS Est: $-1.88
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |